Adalimumab is effective in patients with preradiographic axial spondyloarthritis (PRSPA): Results of a 12-week, randomised controlled trial with a 40-week open-label extension (OLE)

被引：0
|
作者：
Haibel, H. [1 ]
Rudwaleit, M. [1 ]
Amtenbrink, A. [1 ]
Heldmann, F. [2 ]
Listing, J. [3 ]
Wong, R. [4 ]
Kupper, H. [5 ]
Braun, J. [2 ]
Sieper, J. [1 ]
机构：
[1] Charite Univ Med Berlin, D-13353 Berlin, Germany
[2] Ruhrgebeit, Herne, Germany
[3] German Rheumatism Res Ctr, Berlin, Germany
[4] Abbott, Parsippany, NJ USA
[5] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
RHEUMATOLOGY | 2008年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：II80 / II80
页数：1
相关论文
共 50 条
  • [1] Adalimumab is effective in patients with preradiographic axial spondyloarthritis: Results of a 12-week, randomized controlled trial
    Haibel, H.
    Rudwaleit, M.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    [J]. RHEUMATOLOGY, 2007, 46 : I52 - I52
  • [2] Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis: Results of a 20-week, randomized controlled trial with an open-label extension phase
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Kupper, H.
    Braun, J.
    Sieper, J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 14 - 14
  • [3] Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis: Results of a 12-week, randomized controlled trial.
    Haibel, Hildrun
    Rudwaleit, Martin
    Heldmann, Frank
    Listing, Joachim
    Wong, Robert
    Kupper, Hartmut
    Braun, Juergen
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4044 - 4045
  • [4] Efficacy of adalimumab in the treatment of preiradiographic axial spondyloarthritis: Results of a 20-week, randomized controlled trial with an open-label extension phase
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 64 - 64
  • [5] Preliminary results of an open-label, 12-week trial of adalimumab in the treatment of active ankylosing spondylitis
    Haibel, H
    Brandt, HC
    Rudwaleit, M
    Listing, J
    Braun, J
    Kupper, H
    Sieper, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 399 - 399
  • [6] EFFICACY AND SAFETY OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A.
    Nikitina, N.
    Nam, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 718 - 718
  • [7] Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
    Miura, Itaru
    Watabe, Kei
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Maruyama, Hidenori
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 2627 - 2637
  • [8] ASENAPINE AS ADJUNCTIVE TREATMENT FOR BIPOLAR MANIA: A PLACEBO-CONTROLLED 12-WEEK STUDY AND 40-WEEK EXTENSION
    Calabrese, J.
    Stet, L.
    Kotari, H.
    Zhao, J.
    Kouassi, A.
    Szegedi, A.
    Panagides, J.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [9] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [10] EFFECTIVENESS OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN REDUCTION OF ACTIVE SACROILIITIS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A. P.
    Akulova, A. I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 282 - 282
12345